Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

MinuteCE®
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
Jennifer Johnson, MD, PhD; Adam J. Luginbuhl, MD
0.50 credits 5 episodes
- Jennifer Johnson, MD, PhD
- Adam J. Luginbuhl, MD
0.50 credits 5 episodes
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
MinuteCE®
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Adam J. Luginbuhl, MD
0.50 program credits
- Adam J. Luginbuhl, MD
0.50 program credits
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Project Oncology®
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Roberto Leon-Ferre, MD
- Roberto Leon-Ferre, MD
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Project Oncology®
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Amy Comander, MD
- Amy Comander, MD
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
MinuteCE®
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Adam J. Luginbuhl, MD; Jennifer Johnson, MD, PhD
0.50 program credits
- Adam J. Luginbuhl, MD
- Jennifer Johnson, MD, PhD
0.50 program credits
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Project Oncology®
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Charles Turck, PharmD, BCPS, BCCCP; Stephanie Gregory, CNP
- Charles Turck, PharmD, BCPS, BCCCP
- Stephanie Gregory, CNP
Managing Immune-Related Adverse Events in Metastatic NSCLC
Managing Immune-Related Adverse Events in Metastatic NSCLC
Project Oncology®
Managing Immune-Related Adverse Events in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Paul Bunn, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Paul Bunn, MD
Managing High-Risk Subgroups in Metastatic NSCLC
Managing High-Risk Subgroups in Metastatic NSCLC
Project Oncology®
Managing High-Risk Subgroups in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Melina Marmarelis, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Melina Marmarelis, MD
- Deepa Rangachari, MD

Medical News

Medical News
Amivantamab Plus Lazertinib in EGFR-Mutant Lung Cancer with CNS Metastases
05/28/2026
Read more
Medical News
Molecular Profiling Guides Adjuvant Therapy in Endometrial Cancer
05/25/2026
Read more
Medical News
BCG Plus Mitomycin Fails to Improve DFS in ANZUP 1301
05/22/2026
Read more
Medical News
Early Postoperative Intake Linked To Complications After GI Cancer Surgery
05/19/2026
Read more

CME/CE

Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
MinuteCE®
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Jennifer Johnson, MD, PhD
0.50 program credits
- Jennifer Johnson, MD, PhD
0.50 program credits
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CE
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO; Rana McKay, MD
0.25 credits
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CE
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD; Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
- Enriqueta Felip, MD
- Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
Brain Metastases Management: From Detection to Multidisciplinary Care
Brain Metastases Management: From Detection to Multidisciplinary Care
MinuteCE®
Brain Metastases Management: From Detection to Multidisciplinary Care
Barbara O'Brien, MD
1.00 program credit
- Barbara O'Brien, MD
1.00 program credit

Clinical Practice

DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
Project Oncology®
DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
Daniel Hertz, PhD, PharmD
- Daniel Hertz, PhD, PharmD
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Project Oncology®
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Deepa Rangachari, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Deepa Rangachari, MD
Communicating Pathologic Response Results in Resectable NSCLC
Communicating Pathologic Response Results in Resectable NSCLC
Project Oncology®
Communicating Pathologic Response Results in Resectable NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Alexander Spira, MD, PhD, FACP
- Charles Turck, PharmD, BCPS, BCCCP
- Alexander Spira, MD, PhD, FACP
- Robert Merritt, MD
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Project Oncology®
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Brian P. McDonough, MD, FAAFP; Stacey Cohen, MD
- Brian P. McDonough, MD, FAAFP
- Stacey Cohen, MD

Programs

Matching TNBC Treatment Intensity to Patient Needs
Matching TNBC Treatment Intensity to Patient Needs
Project Oncology®
Matching TNBC Treatment Intensity to Patient Needs
Roberto Leon-Ferre, MD
- Roberto Leon-Ferre, MD
Real-World Strategies for Complex cGVHD Treatment Decisions
Real-World Strategies for Complex cGVHD Treatment Decisions
Project Oncology®
Real-World Strategies for Complex cGVHD Treatment Decisions
Brian P. McDonough, MD, FAAFP; Doris M. Ponce, MD, MS
- Brian P. McDonough, MD, FAAFP
- Doris M. Ponce, MD, MS
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
CME/CE
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
Barbara O'Brien, MD
0.25 credits
- Barbara O'Brien, MD
0.25 credits
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Charles Turck, PharmD, BCPS, BCCCP; Laura Alder, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Laura Alder, MD
- Christine Bestvina, MD